Form 4: Imunon Director Pellizzari Acquires Stock Options

Christine A. Pellizzari, a director of Imunon, Inc., acquired stock options on June 12, 2024.

Summary

• Christine A. Pellizzari, a director of Imunon, Inc., filed a Form 4 on June 14, 2024, reporting a transaction.
• On June 12, 2024, Pellizzari acquired stock options to purchase 4,500 shares of Imunon's common stock at an exercise price of $1.22 per share.
• The options vest in three tranches: 1/2 on the grant date, 1/4 on the one-year anniversary, and 1/4 on the two-year anniversary of the grant date.
• Following the transaction, Pellizzari directly owns 18,666 shares of Imunon common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock option acquisition by a director. While insider buying can be a positive signal, the impact is limited in this case.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be informative for investors.

Stakeholder Impact

• The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Imunon, Director, Stock Options, Beneficial Ownership, IMNN, Pellizzari